Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region

Jim Gilbert(Archemix (United States)), Julie Lekstrom-Himes, Debra D. Donaldson, Yih Lee(Millennium Engineering and Integration (United States)), Mingxiu Hu(Millennium Engineering and Integration (United States)), Jing Xu(Millennium Engineering and Integration (United States)), Tim Wyant(Millennium Engineering and Integration (United States)), Michael H. Davidson(University of Chicago)
The American Journal of Cardiology
January 20, 2011
10.1016/j.amjcard.2010.11.005
Cited by 180

Abstract

Related Papers

The Many Roles of Chemokines and Chemokine Receptors in Inflammation
Israel Charo, Richard M. Ransohoff|New England Journal of Medicine|2006|2.5k
Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6
José V. Castell, Marı́a José Gómez-Lechón, Martina David et al.|Hepatology|1990|754
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
Paul M. Ridker|Journal of the American College of Cardiology|2007|608
A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 Expression
Brad H. Rovin, Ling Lu, Ramesh Saxena|Biochemical and Biophysical Research Communications|1999|458
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Paul M. Ridker, Nancy J. Brown, Douglas E. Vaughan et al.|Circulation|2004|424